Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Treasury Shares: 2011-2024

Historic Treasury Shares for Niagen Bioscience (NAGE) over the last 7 years, with Dec 2024 value amounting to $609,000.

  • Niagen Bioscience's Treasury Shares rose 122.08% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 122.08%. This contributed to the annual value of $609,000 for FY2024, which is 3.40% up from last year.
  • Latest data reveals that Niagen Bioscience reported Treasury Shares of $609,000 as of FY2024, which was up 3.40% from $589,000 recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Treasury Shares registered a high of $650,000 during FY2022, and its lowest value of $589,000 during FY2023.
  • For the 3-year period, Niagen Bioscience's Treasury Shares averaged around $616,000, with its median value being $609,000 (2024).
  • Per our database at Business Quant, Niagen Bioscience's Treasury Shares declined by 9.38% in 2023 and then increased by 3.40% in 2024.
  • Over the past 3 years, Niagen Bioscience's Treasury Shares (Yearly) stood at $650,000 in 2022, then dropped by 9.38% to $589,000 in 2023, then increased by 3.40% to $609,000 in 2024.